| scholarly article | Q13442814 |
| P2093 | author name string | D A Fennell | |
| F E Cotter | |||
| M Corbo | |||
| B R Davidson | |||
| A C Okaro | |||
| P2860 | cites work | Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death | Q24311298 |
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration | Q32018881 | ||
| Bcl-2 antisense therapy in multiple myeloma. | Q33587931 | ||
| Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide | Q34478428 | ||
| Mitochondrial permeability transition is a central coordinating event of apoptosis | Q36367290 | ||
| Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats | Q36834046 | ||
| The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides | Q38326195 | ||
| p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases | Q38468205 | ||
| Surgical palliation of small bowel obstruction due to metastatic carcinoma | Q39568458 | ||
| The expression of antiapoptotic proteins Bcl-2, Bcl-X(L), and Mcl-1 in benign, dysplastic, and malignant biliary epithelium | Q40765637 | ||
| Apoptosis: a product of programmed and unprogrammed cell death | Q40828308 | ||
| Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line | Q41085962 | ||
| The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition | Q41150411 | ||
| Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. | Q41298622 | ||
| Apoptosis and the dilemma of cancer chemotherapy. | Q41372240 | ||
| Role of the mitochondrial permeability transition pore in apoptosis | Q41488918 | ||
| Avoidance of apoptosis as a mechanism of drug resistance | Q41626423 | ||
| Mitochondrial permeability transition in apoptosis and necrosis | Q41745048 | ||
| Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target. | Q41919293 | ||
| Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. | Q42553523 | ||
| Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. | Q42754664 | ||
| Leucovorin, 5-fluorouracil, and gemcitabine: a phase I study | Q44865642 | ||
| The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. | Q52528138 | ||
| Photodynamic therapy of nonresectable cholangiocarcinoma. | Q52996561 | ||
| BCL-2 antisense therapy in patients with non-Hodgkin lymphoma | Q61868294 | ||
| bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair | Q64389791 | ||
| Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study | Q68946023 | ||
| Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival | Q68980832 | ||
| Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial | Q70126825 | ||
| Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells | Q73148803 | ||
| [Palliative therapy of gastrointestinal obstruction] | Q73359511 | ||
| Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis | Q73555140 | ||
| Synthesis and biology of a 7-nitro-2,1,3-benzoxadiazol-4-yl derivative of 2-phenylindole-3-acetamide: a fluorescent probe for the peripheral-type benzodiazepine receptor | Q73589795 | ||
| Phase II trial of docetaxel for cholangiocarcinoma | Q74455186 | ||
| A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma | Q74681551 | ||
| Mitochondrial control of apoptosis: the role of cytochrome c | Q77136010 | ||
| Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore | Q77874093 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | 556-561 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells | |
| P478 | volume | 51 |
| Q33841673 | Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors |
| Q43142193 | Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells |
| Q35172032 | Apoptosis and the liver: relation to autoimmunity and related conditions |
| Q38597008 | Cholangiocarcinoma: from molecular biology to treatment |
| Q35789268 | Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development |
| Q51225032 | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. |
| Q39782298 | Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195. |
| Q35847659 | PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism |
| Q39171620 | Sex-dependent mental illnesses and mitochondria |
| Q38938735 | TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance. |
| Q34115304 | Targeting mitochondria for cancer therapy |
| Q37862534 | Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis |
| Q38221277 | The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy. |
Search more.